UPLOAD Filing
Vaxcyte, Inc.
Date: May 14, 2025 · CIK: 0001649094 · Accession: 0000000000-25-005173
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-39323
Letter
Re: Vaxcyte, Inc. Form 10-K for the Fiscal Year Ended December 31, 2024 Filed February 25, 2025 File No. 001-39323 Dear Andrew Guggenhime:
May 14, 2025
Andrew Guggenhime President and Chief Financial Officer Vaxcyte, Inc. 825 Industrial Road, Suite 300 San Carlos, California 94070
We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation
Finance
Office of Life Sciences
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 14, 2025 Andrew Guggenhime President and Chief Financial Officer Vaxcyte, Inc. 825 Industrial Road, Suite 300 San Carlos, California 94070 Re: Vaxcyte, Inc. Form 10-K for the Fiscal Year Ended December 31, 2024 Filed February 25, 2025 File No. 001-39323 Dear Andrew Guggenhime: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences </TEXT> </DOCUMENT>